Were Analysts Bearish Vectura Group plc (LON:VEC) This Week?

April 17, 2018 - By Michael Collier

Vectura Group plc (LON:VEC) Logo

Vectura Group plc (LON:VEC) Ratings Coverage

Among 9 analysts covering Vectura Group PLC (LON:VEC), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Vectura Group PLC had 30 analyst reports since October 31, 2017 according to SRatingsIntel. Shore Capital maintained the shares of VEC in report on Monday, March 12 with “Hold” rating. The firm has “Overweight” rating by JP Morgan given on Friday, January 5. Citigroup maintained Vectura Group plc (LON:VEC) rating on Tuesday, March 20. Citigroup has “Buy” rating and GBX 155 target. The company was maintained on Monday, January 15 by JP Morgan. The stock of Vectura Group plc (LON:VEC) has “Hold” rating given on Wednesday, January 24 by Peel Hunt. Peel Hunt maintained Vectura Group plc (LON:VEC) on Friday, March 23 with “Hold” rating. The rating was maintained by Peel Hunt with “Hold” on Thursday, February 1. JP Morgan maintained the shares of VEC in report on Friday, November 10 with “Overweight” rating. Peel Hunt maintained the stock with “Hold” rating in Wednesday, March 21 report. Numis Securities maintained the shares of VEC in report on Monday, March 12 with “Buy” rating. Below is a list of Vectura Group plc (LON:VEC) latest ratings and price target changes.

04/04/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 111.00 Maintain
23/03/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 120.00 New Target: GBX 111.00 Maintain
22/03/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 140.00 New Target: GBX 140.00 Maintain
22/03/2018 Broker: Stifel Nicolaus Rating: Buy New Target: GBX 151.00 Maintain
22/03/2018 Broker: Numis Securities Rating: Buy New Target: GBX 160.00 Maintain
21/03/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 120.00 New Target: GBX 120.00 Maintain
21/03/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 120.00 New Target: GBX 120.00 Maintain
21/03/2018 Broker: Shore Capital Rating: Hold Maintain
20/03/2018 Broker: Citigroup Rating: Buy New Target: GBX 155.00 Maintain
13/03/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 140.00 New Target: GBX 140.00 Maintain

The stock decreased 6.90% or GBX 7.2125 during the last trading session, reaching GBX 97.2875. About 4.28M shares traded. Vectura Group plc (LON:VEC) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases. The company has market cap of 644.19 million GBP. The companyÂ’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease ; AirFlusal Forspiro for the treatment of asthma and COPD; ADVATE for the treatment of haemophilia A; and Adept for the treatment of surgical adhesions. It currently has negative earnings. The Company’s generic products include VR315, VR506, and VR632 for the treatment of asthma; and Phase III clinical stage products include VR475 for the treatment of severe adult asthma, and VR876 for the treatment of lung diseases, as well as NVA237 and QVA149 for the treatment of COPD for which filed NDA to the Food and Drug Administration.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.